# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA2077091 | F | TP_TRANSPORTER: inhibition of Ochratoxin A uptake in OAT3-expressing S2 cells | 5 | cell-based format | TP-search Transporter Database | |||
2. | ALA2077098 | F | TP_TRANSPORTER: inhibition of Ochratoxin A uptake in OAT1-expressing S2 cells | 5 | cell-based format | TP-search Transporter Database | |||
3. | ALA2077547 | F | TP_TRANSPORTER: inhibition of Ochratoxin A uptake in OAT4-expressing S2 cells | 4 | cell-based format | TP-search Transporter Database | |||
4. | ALA2078401 | F | TP_TRANSPORTER: inhibition of Ochratoxin A uptake (OTA: 1 uM, Citrinin: 200 uM) in Xenopus laevis oocytes | Xenopus laevis | 1 | cell-based format | TP-search Transporter Database | ||
5. | ALA1827079 | F | Cytotoxicity against human KB cells after 72 hrs by SRB assay | Homo sapiens | 18 | cell-based format | Scientific Literature | ||
6. | ALA1827080 | F | Cytotoxicity against human HL60 cells after 72 hrs by MTT assay | Homo sapiens | 16 | cell-based format | Scientific Literature | ||
7. | ALA1827081 | F | Cytotoxicity against human HCT116 cells after 72 hrs by SRB assay | Homo sapiens | 16 | cell-based format | Scientific Literature | ||
8. | ALA1909163 | B | DRUGMATRIX: Leukotriene LTC4 Synthase enzyme inhibition (substrate: LTA4) | Cavia porcellus | 871 | tissue-based format | DrugMatrix | ||
9. | ALA1909164 | B | DRUGMATRIX: Cysteinyl leukotriene receptor 1 radioligand binding (ligand: [3H]LTD4) | 871 | cell membrane format | DrugMatrix | |||
10. | ALA1909165 | B | DRUGMATRIX: Lipoxygenase 15-LO enzyme inhibition (substrate: Linoleic acid) | Oryctolagus cuniculus | 871 | tissue-based format | DrugMatrix | ||
11. | ALA1909166 | B | DRUGMATRIX: Melanocortin MC3 radioligand binding (ligand: [125I] NDP-alpha-MSH) | 871 | cell membrane format | DrugMatrix | |||
12. | ALA1909167 | B | DRUGMATRIX: Melanocortin MC4 radioligand binding (ligand: [125I] NDP-alpha-MSH) | 871 | cell membrane format | DrugMatrix | |||
13. | ALA1909168 | B | DRUGMATRIX: Melanocortin MC5 radioligand binding (ligand: [125I] NDP-alpha-MSH) | 871 | cell membrane format | DrugMatrix | |||
14. | ALA1909169 | B | DRUGMATRIX: Monoamine Oxidase MAO-A enzyme inhibition (substrate: Kynuramine) | 871 | cell-based format | DrugMatrix | |||
15. | ALA1909170 | B | DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine) | 871 | cell membrane format | DrugMatrix | |||
16. | ALA1909171 | B | DRUGMATRIX: Muscarinic M2 radioligand binding (ligand: [3H] N-Methylscopolamine) | 871 | cell membrane format | DrugMatrix | |||
17. | ALA1909172 | B | DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine) | 871 | cell membrane format | DrugMatrix | |||
18. | ALA1909173 | B | DRUGMATRIX: Muscarinic M4 radioligand binding (ligand: [3H] N-Methylscopolamine) | 871 | cell membrane format | DrugMatrix | |||
19. | ALA1909174 | B | DRUGMATRIX: Muscarinic M5 radioligand binding (ligand: [3H] N-Methylscopolamine) | 871 | cell membrane format | DrugMatrix | |||
20. | ALA1909175 | B | DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY) | 871 | cell membrane format | DrugMatrix |